Product Information
CYPROHEPTADINE 4 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0679 per EA under NDC 62135023690. Its NADAC has been published 178 times since May 10, 2023.
FDA first approved this application on May 26, 1983. Its Orange Book therapeutic-equivalence code is AA.
Strength
4 mg/1
Manufacturer
Chartwell RX LLCNDC
62135023690
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CYPROHEPTADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA088212FDA Approved
5/26/1983
TE Code
AA
On Market Since
5/26/1983
Price Statistics
The NADAC for CYPROHEPTADINE 4 MG TABLET has been published 178 times since May 10, 2023, and over the history we have for it it has declined 27.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0679 per EA |
|---|---|
| All-time high | $0.1072 (Mar 13, 2024) |
| All-time low | $0.0644 (Apr 22, 2026) |
| 52-week high | $0.0775 |
| 52-week low | $0.0644 |
| Median price | $0.0810 |
| Average price | $0.0793 |
| Largest weekly change | -22.4% (Nov 20, 2024) |
| Weeks tracked | 178 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cyproheptadine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CYPROHEPTADINE 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYPROHEPTADINE 4 MG TABLET, manufactured by Chartwell RX LLC, is $0.0679 per EA (NDC 62135023690), effective Sep 30, 2026.
How has the price of CYPROHEPTADINE 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYPROHEPTADINE 4 MG TABLET has declined 27.7%. It has been tracked across 178 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for CYPROHEPTADINE 4 MG TABLET?
Since May 10, 2023, the NADAC for CYPROHEPTADINE 4 MG TABLET has ranged from a low of $0.0644 (Apr 22, 2026) to a high of $0.1072 (Mar 13, 2024), with a median of $0.0810 per EA.
Are there cheaper alternatives to CYPROHEPTADINE 4 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYPROHEPTADINE 4 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYPROHEPTADINE 4 MG TABLET?
CYPROHEPTADINE 4 MG TABLET (NDC 62135023690) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.